Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Viatris Innovation Gmbh

Clinical trials sponsored by Viatris Innovation Gmbh, explained in plain language.

Now part of Viatris Inc. VTRS NASDAQ

A German subsidiary of Viatris, a global healthcare company making generic and branded medicines.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 2 Not yet finished but already full! 4 Completed 11 Terminated 1

New drug combo safety checked in healthy volunteers

Knowledge-focused Terminated

This early-stage study looked at whether a new drug called ACT-334441 is safe when taken with two common heart medications (diltiazem and atenolol). Ten healthy volunteers were enrolled to check heart rate, blood pressure, and how the drugs interact. The study was terminated earl…

Phase: PHASE1 • Sponsor: Viatris Innovation GmbH • Aim: Knowledge-focused

Last updated Jun 27, 2026 07:51 UTC